Microfluidic Droplet Array for Nucleic Acid Quantification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current lab-on-a-chip devices face limitations in detecting and quantifying nucleic acids over a high dynamic range due to limited compartmentalization and volume throughput, leading to lower accuracy and resolution compared to analog counterparts, especially in digital PCR applications.

Innovation Solution

A microfluidic device generates multiple small reaction volumes within an oil carrier, allowing for real-time fluorescent monitoring of nucleic acid amplification, enabling both digital and analog quantification by determining the initial concentration based on cycle threshold and fluorescence ratios, thereby expanding the dynamic range and accuracy of nucleic acid detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If on-chip digital PCR is used to provide compartmentalized reactors for single-copy nucleic acid detection, then measurement precision is improved, but dynamic range is reduced by three to four orders of magnitude compared to analog counterparts

Engineering Contradiction:
Improvequantitative resolutionVSAvoiddynamic range
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The system segments the nucleic acid sample into multiple discrete reaction compartments (micro-reactors or droplets), where each compartment independently amplifies and detects target sequences. This segmentation enables digital quantification by counting positive compartments, achieving high measurement precision while the overall system maintains extended dynamic range through the large number of parallel compartments

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention transitions from traditional single-reaction analog detection to multi-compartment digital detection, adding the dimension of spatial distribution across numerous independent reactors. This dimensional expansion allows simultaneous achievement of high precision (through individual compartment analysis) and extended dynamic range (through population statistics of many compartments)

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If low concentrations of DNA are used relative to reactor number for single molecule encapsulation, then measurement precision is improved, but productivity is reduced due to limited volume throughput

Engineering Contradiction:
Improvesingle molecule detection accuracyVSAvoidvolume throughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The system creates numerous copies of the sample across many parallel reaction compartments, where each compartment receives a stochastic distribution of target molecules. This copying approach enables single-molecule detection precision while maintaining productivity by processing large total volumes through the collective capacity of all compartments

Inventive Principle:
Principle #26Copying

Solution Approach 2:

By segmenting the total reaction volume into many small compartments, the system achieves both high precision (through single-molecule sensitivity in each compartment) and maintained productivity (by processing large aggregate volumes across all compartments in parallel)

Inventive Principle:
Principle #1Segmentation

3Measurement precision

If real-time fluorescence measurements are implemented to provide temporal information about PCR amplification, then measurement precision is improved, but device complexity increases

Engineering Contradiction:
Improvetemporal amplification informationVSAvoidreal-time monitoring system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system replaces complex mechanical real-time monitoring of each individual compartment with a simpler endpoint fluorescence reading approach. By using robust DNA polymerases that maintain exponential amplification kinetics, the invention achieves equivalent temporal information through endpoint measurements, avoiding the need for complex real-time imaging systems while maintaining measurement precision

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention changes the detection parameter from real-time temporal monitoring to endpoint fluorescence intensity measurement. By leveraging the exponential amplification特性 and using highly sensitive endpoint detection, the system achieves the same quantitative precision without the device complexity of real-time monitoring systems

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves significantly higher dynamic ranges and accuracy in nucleic acid quantification, enabling detection from a single strand to high concentrations with enhanced resolution and replica accuracy, surpassing previous methods by allowing for precise low-concentration detection and extended dynamic range in digital and real-time PCR analysis.

Implementation Method 1

Each reaction volume contains sufficient nucleotides, primers, polymerase enzyme, DNA sequence specific fluorescent probes and buffer to amplify and detect target specific nucleic acids

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS10081017B2Method and system for ultra-high dynamic range nucleic acid quantification
Publication Date: 2018.09.25 RGT UNIV OF CALIFORNIA
  • US10081017B2 patent drawing
  • US10081017B2 patent drawing
  • US10081017B2 patent drawing

AI summary

A method of quantifying nucleic acids in a sample includes generating a plurality of droplets in oil within a microfluidic device, wherein at least some of the droplets comprise a nucleic acid, amplification reagents, and a fluorescent probe or dyes contained therein. The droplets are delivered to a collection chamber to form an array of droplets. The droplets are subject to thermal cycling within the collection chamber a plurality of times to perform nucleic acid amplification within the droplets. The array of droplets is imaged during the plurality of thermal cycles as well as at a thermal cycle endpoint. An initial concentration of nucleic acid in the sample is calculated based on at least one of: a ratio of aqueous phase droplets exhibiting fluorescence within the array at the thermal cycle endpoint or a cycle threshold (Ct) of one or more aqueous phase droplets within the array.